Navigation Links
Patients perceived cancer care unaffected by lower Medicare reimbursements

Patients perceive no significant change in the quality of care for cancer since the United States government passed the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) according to a study published in the November 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The new study, led by Jolle Friedman from the Duke Clinical Research Institute in Durham, North Carolina, reports that, compared to patients treated before the MMA, there was no difference in the time to and location of treatment for patients with cancer treated after the Act was signed into law. Furthermore, patients remain highly satisfied with their cancer treatment.

In 2003 the MMA was signed into law by President Bush and was the most comprehensive restructuring of the Medicare system since its introduction in 1965. Changes included a new prescription drug benefit, managed care insurer access, and $25 billion allocated to rural hospitals. One key provision, however, was a significant reduction in Medicare reimbursement to healthcare providers that went into effect January 1, 2005. In particular, cancer treatment was targeted with reduction because it was considered by legislators to have been overly generous.

The effect of these reimbursement cuts on patient care has been unclear. On the one hand, a study commissioned by U.S. government found that patients did not perceive any differences in care. However, other anecdotal sources report that oncologists are downsizing their practices in many markets by eliminating nurses and other staff and by closing satellite offices, requiring patients to travel farther for treatment, particularly in rural areas Dr. Schulman and colleagues surveyed 1,421 cancer patients treated before (n=684) and after (n=737) the MMA to compare patients perceptions of access to and satisfaction with oncologists care.

They found that regardless of age, patients treated pre- and post-MMA reported a median wait to treatment time of 21 days and an average travel time of 30 minutes. Overall, there was no significant difference in treatment location between the groups. However, a small trend in change of location was observed for patients living in rural areas and patients with Medicare and no supplemental insurance. The number of patients in these subgroups was too small to make an association.

In addition, the authors found that patient satisfaction with care by their oncologist and infusion center staff was similar in the pre- and post-MMA groups, regardless of age. For example, among patients 65 years and older, 65 percent and 76 percent of patients from both groups were very satisfied with their oncologist and infusion staff, respectively.

Dr. Schulman and his co-authors conclude that overall, our findings do not support generalizations from anecdotal reports that patients are being affected by these changes as a result of the MMA. However, this study suggests a possible impact by the MMA on vulnerable populations, such as those in rural areas and those with only Medicare insurance, which should be investigated.


Contact: Amy Molnar
John Wiley & Sons, Inc.

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. HIV infected patients can travel safely abroad
7. New vaccine helps allergy and asthma patients
8. Doctors operate upon patients in candlelight- latest from the quake scene
9. New vaccine helps allergy and asthma patients
10. Are cancer patients being taken for a ride?
11. Alternative medicine more popular among HIV positive patients
Post Your Comments:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 Halo Labs announces the European launch of their ... HORIZON at MIBio 2017 in Cambridge, U.K ... matter in biopharmaceutical samples with unprecedented speed and sensitivity while using ... Backgrounded Membrane Imaging. ... subvisible particle analysis system ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/22/2017)... SAN DIEGO , Sept. 22, 2017 ... ll medical device is now successfully helping those with ... Union. Fibromyalgia diagnosed Amanda in ... getting dressed and washing my hair, experiencing no sleep ... body in painful spasm… I cannot recommend [the AVACEN ...
Breaking Medicine Technology: